Page last updated: 2024-10-21

pk 11195 and Recrudescence

pk 11195 has been researched along with Recrudescence in 3 studies

PK-11195 : A monocarboxylic acid amide obtained by formal condensation of the carboxy group of 1-(2-chlorophenyl)isoquinoline-3-carboxylic acid with the amino group of sec-butylmethylamine

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (33.33)29.6817
2010's1 (33.33)24.3611
2020's1 (33.33)2.80

Authors

AuthorsStudies
Sucksdorff, M1
Matilainen, M1
Tuisku, J1
Polvinen, E1
Vuorimaa, A1
Rokka, J1
Nylund, M1
Rissanen, E1
Airas, L1
Mendonça-Torres, MC1
Roberts, SS1
Debruyne, JC1
Versijpt, J1
Van Laere, KJ1
De Vos, F1
Keppens, J1
Strijckmans, K1
Achten, E1
Slegers, G1
Dierckx, RA1
Korf, J1
De Reuck, JL1

Other Studies

3 other studies available for pk 11195 and Recrudescence

ArticleYear
Brain TSPO-PET predicts later disease progression independent of relapses in multiple sclerosis.
    Brain : a journal of neurology, 2020, 12-05, Volume: 143, Issue:11

    Topics: Adult; Brain; Cohort Studies; Disability Evaluation; Disease Progression; Female; Humans; Isoquinoli

2020
The translocator protein (TSPO) ligand PK11195 induces apoptosis and cell cycle arrest and sensitizes to chemotherapy treatment in pre- and post-relapse neuroblastoma cell lines.
    Cancer biology & therapy, 2013, Volume: 14, Issue:4

    Topics: Antineoplastic Combined Chemotherapy Protocols; Apoptosis; ATP-Binding Cassette Transporters; Carbop

2013
PET visualization of microglia in multiple sclerosis patients using [11C]PK11195.
    European journal of neurology, 2003, Volume: 10, Issue:3

    Topics: Adult; Age Factors; Antineoplastic Agents; Brain Mapping; Cohort Studies; Female; Humans; Isoquinoli

2003